Comprehensive Oncology · Multidisciplinary Care · Immunotherapy
Pancreatic Cancer Treatment in Cuba
Pancreatic cancer is among the most challenging cancers to treat. Cuba's oncology infrastructure provides international patients with comprehensive evaluation and multidisciplinary treatment — including surgical options (Whipple procedure, distal pancreatectomy), chemotherapy, radiation therapy, and access to immunotherapy agents such as CIMAher (nimotuzumab) for EGFR-expressing tumors. Treatment eligibility depends on the stage, tumor location, and the patient's overall clinical condition, as determined by the treating medical team.
Pancreatic Cancer — Treatment Video
Combating Cancer in Cuba — Pancreatic Oncology
Visual Guide
Understanding pancreatic cancer care in Cuba
See the specialized facilities and patient-centered care that define our pancreatic cancer treatment programs.
Specialized Oncology care in Cuba
Comprehensive international patient coordination in Havana
Clinical Evidence & Outcomes
The science behind pancreatic cancer treatment in Cuba
Our clinical programs are grounded in peer-reviewed research and coordinated with Cuba's biotechnology institutions. Individual results vary and are confirmed during personalized evaluation.
CIMAher® (nimotuzumab)
EGFR-Expressing Pancreatic Tumors
Nimotuzumab targets the epidermal growth factor receptor (EGFR), which is expressed in many pancreatic tumors. It may be considered as part of a comprehensive treatment plan for eligible patients, subject to molecular testing and the treating medical team's assessment.
Source: CIM — Center of Molecular Immunology
Multidisciplinary Oncology Model
Comprehensive Pancreatic Cancer Care
Pancreatic cancer requires a multimodal approach. Cuba's oncology infrastructure provides surgical options, systemic chemotherapy, and radiation therapy. Treatment sequencing depends on tumor resectability, stage, and the patient's overall health, as determined by the multidisciplinary tumor board.
Source: SMC Salud — Office of Medical Affairs
International Patient Coordination
Comprehensive Support
SMC Salud coordinates the full international patient pathway for pancreatic cancer patients, including expedited medical record review, travel logistics, and post-treatment telemedicine follow-up.
Source: SMC Salud — International Patient Services
Outcomes shown reflect published clinical data and aggregate results. Individual results vary based on diagnosis, disease stage, and overall health, and are confirmed during a personalized medical evaluation. This page is for educational purposes and is not a substitute for professional medical advice.
References & Citations
Clinical content on this page is supported by peer-reviewed research and institutional publications. Individual treatment outcomes vary and are confirmed during personalized medical evaluation.
Our Comprehensive Approach
CIMAher® (nimotuzumab)
Anti-EGFR monoclonal antibody that may be considered for EGFR-expressing pancreatic tumors, subject to medical evaluation.
Comprehensive Evaluation
Oncology review of imaging, biopsy, CA 19-9 markers, and prior treatments to assess treatment options.
Multidisciplinary Tumor Board
Surgical oncologists, medical oncologists, radiation oncologists, and gastroenterologists collaborate on each case.
Surgical Oncology
Access to pancreatic surgery including Whipple procedure (pancreaticoduodenectomy) and distal pancreatectomy where medically appropriate.
Supportive Care
Pain management, nutritional support, pancreatic enzyme replacement, and palliative care services.
International Patient Care
Full coordination: medical visa, accommodation, interpretation, and 24/7 support in Havana.
Pancreatic Cancer — Treatment & Medication
Treatment Options Available in Cuba
Cuba offers comprehensive pancreatic cancer treatment including surgical options (Whipple procedure, distal pancreatectomy), chemotherapy, radiation therapy, and access to CIMAher® (nimotuzumab) for EGFR-expressing tumors. Treatment is coordinated by a multidisciplinary team. No therapy guarantees a cure, and not every patient will benefit. Treatment suitability is determined after medical evaluation of resectability, stage, and overall health.
Treatment suitability is determined after medical evaluation. No therapeutic outcome is guaranteed, and not every patient will benefit. Each case is reviewed individually by the medical team.
Pancreatic Cancer — Required Documents
Documents for Medical Evaluation
Providing these documents helps our medical team review your case before you travel. You do not need to send every document to begin — send what you have available.
Biopsy / Pathology Report
Confirmed diagnosis and tumor type
CT / MRI / PET-CT
Recent abdominal and staging imaging
Oncology Reports
Specialist consultation and treatment notes
Previous Treatment Records
Surgery, chemotherapy, or radiation history
Current Medications
All medications currently being taken
Recent Laboratory Results
Blood work and CA 19-9 tumor marker
Clinical Evidence
Patient Safety
Expert Specialists
International Standards
Frequently Asked Questions
Questions from international patients
Cuba offers comprehensive pancreatic cancer treatment including surgical options (Whipple procedure, distal pancreatectomy), chemotherapy, radiation therapy, and access to immunotherapy agents such as CIMAher (nimotuzumab) for EGFR-expressing tumors. The specific treatment plan is determined by the medical team based on stage, tumor resectability, and the patient's clinical condition.
Find country-specific information, testimonials, and FAQs for your region.
Could This Treatment Be Right for You?
Submit your medical records for review by our medical team. We will assess your case and provide a personalized recommendation. Treatment suitability is determined only after medical evaluation.